BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8361328)

  • 1. Ouabain causes kaliuresis and works synergistically with aldosterone in vivo.
    Sekihara H; Yazaki Y
    Life Sci; 1993; 53(12):975-80. PubMed ID: 8361328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5 alpha-Dihydro-11-deoxycorticosterone as a mineralocorticoid agonist and antagonist: evidence for a weak mineralocorticoid as an antagonist of potent mineralocorticoids.
    Sekihara H; Yazaki Y
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):235-8. PubMed ID: 8499332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mineralocorticoids on Na+ and K+ excretion in the adrenalectomized rat.
    Horisberger JD; Diezi J
    Am J Physiol; 1983 Jul; 245(1):F89-99. PubMed ID: 6869541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aldosterone-induced antinatriuresis and kaliuresis by actinomycin D.
    Horisberger JD; Diezi J
    Am J Physiol; 1984 Feb; 246(2 Pt 2):F201-4. PubMed ID: 6696121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.
    Ehrlich EN; Lindheimer MD
    J Clin Invest; 1972 Jun; 51(6):1301-9. PubMed ID: 4336938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 19-Oxoandrost-4-ene-3,17-dione amplifies the action of aldosterone.
    Sekihara H; Yazaki Y
    J Steroid Biochem Mol Biol; 1993 Jul; 46(1):69-72. PubMed ID: 8338792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies of the mineralocorticoid activity of 19-oxo-deoxycorticosterone.
    Kenyon CJ; Saccoccio NA; Morris DJ
    Endocrinology; 1984 Aug; 115(2):535-7. PubMed ID: 6745168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules.
    Mujais SK; Chekal MA; Jones WJ; Hayslett JP; Katz AI
    J Clin Invest; 1985 Jul; 76(1):170-6. PubMed ID: 2991336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of ouabain on urinary output of potassium in rats loaded with NaCl (author's transl)].
    Monma Y; Okuoka Y; Tanabe T
    Nihon Yakurigaku Zasshi; 1980 May; 76(4):265-70. PubMed ID: 7450619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant aspects of aldosterone resistance in potassium depletion.
    Mujais SK; Chen Y; Nora NA
    Am J Physiol; 1992 Jun; 262(6 Pt 2):F972-9. PubMed ID: 1320334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of exogenous ouabain and chronic mineralocorticoid treatment in the kidney of the conscious sheep.
    Yates NA; McDougall JG
    Clin Exp Pharmacol Physiol; 1997 Jan; 24(1):57-63. PubMed ID: 9043806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of aldosterone and ouabain on cation concentrations in incubated renal slices.
    Osore H; Gilbert J
    Biochem Pharmacol; 1982 Aug; 31(16):2571-4. PubMed ID: 7138555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sheep renal potassium excretion: efferent kaliuretic regulatory factors.
    Rabinowitz L; Sarason RL; Yamauchi H
    Am J Physiol; 1984 Sep; 247(3 Pt 2):F520-6. PubMed ID: 6476127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute mineralocorticoid and glucocorticoid receptor blockade on the excretion of an acute potassium load in healthy humans.
    van Buren M; Boer P; Koomans HA
    J Clin Endocrinol Metab; 1993 Oct; 77(4):902-9. PubMed ID: 8408463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of endogenous mineralocorticoids on the composition of fetal urine.
    Kairaitis K; Lumbers ER
    J Dev Physiol; 1990 Jun; 13(6):347-51. PubMed ID: 2084194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal potassium adaptation in the rat: role of glucocorticoids and aldosterone.
    Adam WR; Goland GJ; Wellard RM
    Am J Physiol; 1984 Mar; 246(3 Pt 2):F300-8. PubMed ID: 6703064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone.
    Bamberg K; William-Olsson L; Johansson U; Jansson-Löfmark R; Hartleib-Geschwindner J
    J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827449. PubMed ID: 30813831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone.
    Kenyon CJ; Brem AS; McDermott MJ; Deconti GA; Latif SA; Morris DJ
    Endocrinology; 1983 May; 112(5):1852-6. PubMed ID: 6403339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "mineralocorticoid-like" actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.
    Souness GW; Morris DJ
    Endocrinology; 1991 Nov; 129(5):2451-6. PubMed ID: 1657575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.